Rare diseases
Investigational molecules
Locations
4149 Liberty Canyon Road, 91301-5146, United States
Acelyrin Inc. demonstrates a concentrated focus on developing therapeutic interventions for rheumatologic conditions and autoimmune disorders. The company's research portfolio emphasizes conditions characterized by chronic inflammation and immune system dysregulation affecting connective tissues and joints.
The therapeutic development programs target inflammatory pathways implicated in these debilitating conditions, with particular attention to diseases that significantly impact patient mobility and quality of life through progressive joint damage and systemic inflammation.
Acelyrin Inc. runs clinical trials in conditions such as Psoriatic arthropathy, Uveitis, Chorioretinitis, Hidradenitis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Bulgaria
Austria
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
